Publication date: Sep 09, 2025
This article provides a focused update to the clinical practice guideline on the treatment and management of patients with coronavirus disease 2019 (COVID-19), developed by the Infectious Diseases Society of America. The guideline panel presents a recommendation on the use of abatacept in hospitalized adults with severe or critical COVID-19. The recommendation is based on evidence derived from a systematic literature review and adheres to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach.
Open Access PDF
| Concepts | Keywords |
|---|---|
| America | abatacept |
| Coronavirus | COVID-19 |
| Covid | guideline |
| Hospitalized | SARS-CoV-2 |
| Systematic |
Original Article
(Visited 8 times, 1 visits today)